The Appen share price has surged 61% higher in 2018

The Appen Ltd (ASX:APX) share price has been a big mover in 2018. Is it too late to invest?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Appen Ltd (ASX: APX) share price has been one of best performers on the Australian share market this year with a gain of 61%.

This compares to the ASX 200 and its year to date decline of just over 6%.

Why is the Appen share price up 61% this year?

A good portion of its gain has come in recent weeks following the release of a positive trading update.

That update revealed that the developer of high-quality, human annotated datasets for machine learning and artificial intelligence has continued to experience strong demand for its services in recent months.

This has led to a sharp increase in monthly revenues from existing projects from existing customers. As a result, management raised its underlying EBITDA guidance to the range of $62 million to $65 million in FY 2018.

This compares to its previous guidance of between $54 million and $59 million and will be a 120% to 131% increase on FY 2017's result.

While some of this year's EBITDA is being generated by the Leapforce business which was acquired late in 2017 for US$80 million, the majority of its growth is organic.

Is it too late to invest in Appen?

I don't believe it is too late to invest in Appen's shares. After all, management believes strong tailwinds are fuelling a need for AI data. And due to its global presence and industry-leading status, it believes it is strongly positioned and executing well.

Furthermore, at 29x estimated FY 2019 earnings, I think Appen is arguably the best value share in the WAAAX group right now ahead of Altium Limited (ASX: ALU) and Xero Limited (ASX: XRO).

All in all, I think this could make it worth taking advantage of any selling in the tech sector today to pick up shares with a long term view.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Altium, Appen Ltd, and Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »